← All industries
Industry playbook

Pharmaceutical Importers: Tariff Refund Playbook

Pharmaceutical Importers Tariff Refund Playbook: IEEPA, Drawback, and 2026 CAPE Filing

TL;DR

Pharmaceutical active ingredients and finished drugs imported from IEEPA-countries during 2025 are largely refund-eligible, with caveats around FDA registration and specific CBP categorical exclusions.

Typical 2025 exposure: 2 to 6 percent of 2025 landed cost. Primary ports of entry: New York / Newark, Chicago O'Hare, Philadelphia, Los Angeles / Long Beach. Our licensed broker partners have filed on behalf of importers in this vertical and can handle claim preparation under 19 CFR 111.

1. The Pharmaceutical Importers Refund Profile

Pharmaceutical active ingredients and finished drugs imported from IEEPA-countries during 2025 are largely refund-eligible, with caveats around FDA registration and specific CBP categorical exclusions.

Top HTS lines for this vertical:

  • pharmaceutical products (HS 30)
  • organic chemicals (HS 29)
  • optical instruments (HS 90)
  • plastics (HS 39)

IOR posture: Manufacturers, importers-of-record per FDA registration, and some distributors. Check 7501.

2. The Most Common Mistake

Missing the Section 232 pharmaceutical investigation overlap. Refund posture depends on the specific CBP message number covering the entry.

Our AI analyzer flags these kinds of issues automatically on 7501 upload. For a faster read, the IEEPA Refund Calculator returns a refund range from four inputs.

3. What You Should Do This Week

IEEPA calculator for base refund, AI analyzer for line-level HTS breakdown, consultation call to review Section 232 overlap if any.

Concrete three-step path:

  1. Pull your 2025 ACE entry history. Everything from April 2, 2025 to February 20, 2026.
  2. Identify the IEEPA-dutied lines. HTS codes starting with 9903.01 indicate IEEPA exposure. Your broker can export this as a single CSV.
  3. Calculate and prioritize. Claims above $250,000 get a direct broker review. Claims under that can go through the calculator and AI analyzer first to right-size the engagement.

4. Compliance Posture

Pharmaceutical Importers importers face the same industry-wide trap: refund mills quoting 30 percent contingency fees and promising "file today." Two reasons to walk away:

  1. 19 USC 1641 makes customs business without a licensed broker a federal offense. Every filing we route goes through a licensed customs broker partner under 19 CFR 111.
  2. FTC Section 5 prohibits unsubstantiated refund claims. We publish estimate ranges with the explicit "subject to CBP adjudication" caveat. Mills that promise a dollar figure on a cold-call intro are the ones the FTC pays attention to.

5. Next Steps

Tariff Refund Credits is a lead-generation service. Customs business is performed exclusively by our licensed customs broker partners under 19 CFR 111. Not legal or tax advice.

Frequently asked questions

Not legal advice. Customs business performed by licensed customs broker partners under 19 CFR 111. Refund estimates subject to CBP adjudication.

Your Pharmaceutical Importers refund estimate in 60 seconds.

Run the IEEPA calculator or upload your Form 7501 for a line-by-line AI extraction.

IEEPA Refund Calculator →Upload 7501
Other industry playbooks
Amazon FBA SellersApparel and TextilesAutomotive PartsChemicals and PlasticsDTC and Shopify BrandsConsumer Electronics